Central Park Hematology and Oncology

New York, New York 10028-0506

0 studies enrolling now · 1 studies all time

What they study most

Advanced Unresectable or Metastatic Solid Malignancy

Studies at this site

• A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response — Completed